Cardiovascular Surgical Devices Market Report 2024 (Global Edition)

Global Cardiovascular Surgical Devices Market Report 2024 Market Size Split by Type (Interventional Cardiac Surgery, Cardiac Rhythm Management, Traditional Cardiac Surgery, Others), by Technology (Per...

Cardiovascular Surgical Devices Market Report Description

We have various report editions of Cardiovascular Surgical Devices Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Cardiovascular Surgical Devices Market Insights Video

Competitive Landscape of the Cardiovascular Surgical Devices Market

The competitive landscape of the cardiovascular surgical devices market is characterized by prominent players such as Medtronic plc, Abbott Laboratories, and Edwards Lifesciences Corporation dominating with their innovative technologies and extensive product portfolios. These companies focus on developing advanced devices like stents, heart valves, and pacemakers, leveraging technological advancements such as minimally invasive procedures and robotic-assisted surgeries. Regional players also contribute significantly, particularly in emerging markets, fostering competition and driving innovation in cardiovascular surgical interventions globally.

October 2022: Biosense Webster, Inc., a division of Johnson & Johnson MedTech, has introduced the HELIOSTAR Balloon Ablation Catheter in Europe. This catheter is designed for catheter-based cardiac electrophysiological mapping of the atria, as well as for cardiac ablation when used with a compatible multi-channel RF generator. (Source: https://www.jnjmedtech.com/en-EMEA/news-events/biosense-webster-launches-heliostartm-europe-first-radiofrequency-balloon-ablation)

Top Companies Market Share in Cardiovascular Surgical Devices Industry: (In no particular order of Rank)

• Medtronic plc (Ireland)
• Abbott Laboratories (USA)
• Edwards Lifesciences Corporation (USA)
• Boston Scientific Corporation (USA)
• Terumo Corporation (Japan)
• Johnson & Johnson (USA)
• LivaNova PLC (UK)
• Teleflex Incorporated (USA)
• MicroPort Scientific Corporation (China)
• Merit Medical Systems
• Inc. (USA)
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Cardiovascular Surgical Devices Market

Which Region Dominates the Cardiovascular Surgical Devices Market in 2024?

According to Cognitive Market Research, North America dominated the market in 2024. It accounted for around 40% of the global revenue because of the area's advanced healthcare infrastructure, high healthcare expenditure, and a significant prevalence of cardiovascular diseases. The region is also at the forefront of technological advancements in medical devices, fostering innovation and adoption of sophisticated surgical techniques. Favorable reimbursement policies and robust regulatory frameworks further support market growth. Additionally, strong presence of major players like Medtronic, Abbott Laboratories, and Boston Scientific contributes to North America's dominant position in the global market.

Which Region is Expanding at the Fastest CAGR?

The Asia Pacific region is experiencing the fastest growth in the cardiovascular surgical devices market due to several factors. Rapid economic development has led to improved healthcare infrastructure and increased healthcare spending, expanding access to advanced medical treatments. Rising incidence of cardiovascular diseases, attributed to aging populations and lifestyle changes, is driving demand for surgical interventions. Moreover, government initiatives to enhance healthcare access and advancements in medical technology adoption contribute to the region's accelerated growth in the cardiovascular surgical devices market.

 

The current report Scope analyzes Cardiovascular Surgical Devices Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Cardiovascular Surgical Devices Market

According to Cognitive Market Research, the global Cardiovascular Surgical Devices market size was estimated at USD 2,542.2 Million, out of which North America held the major market of more than 40% of the global revenue with a market size of USD 1,016.88 million in 2024 and will grow at a compound annual growth rate (CAGR) of 2.0% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Cardiovascular Surgical Devices market with a market size of USD 802.32 million in 2024 and is projected to grow at a CAGR of 1.8% during the forecast period. The demand is amplified by the nation's high prevalence of cardiovascular diseases.
• The Canada Cardiovascular Surgical Devices market had a market share of USD 122.03 million in 2024 and is projected to grow at a CAGR of 2.8% during the forecast period. Canada's robust consumer demand and a diverse range of applications to increased usage of Cardiovascular Surgical Devices.
• The Mexico Cardiovascular Surgical Devices market is projected to witness growth at a CAGR of 2.3% during the forecast period, with a market size of USD 92.54 million in 2024.

Europe Cardiovascular Surgical Devices Market

According to Cognitive Market Research, the global Cardiovascular Surgical Devices market size was estimated at USD 2,542.2 Million out of which Europe held the market of more than 30% of the global revenue with a market size of USD 762.66 million in 2024 and will grow at a compound annual growth rate (CAGR) of 2.3% from 2024 to 2031.

• The United Kingdom Cardiovascular Surgical Devices market had a market share of USD 128.13 million in 2024 and is projected to grow at a CAGR of 3.1% during the forecast period. In the UK, Cardiovascular Surgical Devices sales witness an upswing due to the nation's aging population, high prevalence of cardiovascular diseases, and advanced healthcare infrastructure.
• The France Cardiovascular Surgical Devices market is projected to witness growth at a CAGR of 1.5% during the forecast period, with a market size of USD 70.16 million in 2024.
• According to Cognitive Market Research, the Germany Cardiovascular Surgical Devices market size was valued at USD 151.01 million in 2024 and is projected to grow at a CAGR of 2.5% during the forecast period. In Germany, Cardiovascular Surgical Devices sales surged due to supportive government policies, strong healthcare expenditure, and ongoing advancements in medical technology.
• The Italy Cardiovascular Surgical Devices market is projected to witness growth at a CAGR of 1.7% during the forecast period, with a market size of USD 65.59 million in 2024.
• The Russia Cardiovascular Surgical Devices market is projected to witness growth at a CAGR of 1.3% during the forecast period, with a market size of USD 118.21 million in 2024.
• The Spain Cardiovascular Surgical Devices market is projected to witness growth at a CAGR of 1.4% during the forecast period with a market size of USD 62.54 million in 2024
• The Luxembourg Cardiovascular Surgical Devices market is projected to witness growth at a CAGR of 2.4% during the forecast period, with a market size of USD 23.64 million in 2024.
• The Portugal Cardiovascular Surgical Devices market is projected to witness growth at a CAGR of 2.1% during the forecast period, with a market size of USD 16.02 million in 2024.

Asia Pacific Cardiovascular Surgical Devices Market

According to Cognitive Market Research, the global Cardiovascular Surgical Devices market size was estimated at USD 2,542.2 Million, out of which Asia Pacific held the market of around 23% of the global revenue with a market size of USD 584.71 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.8% from 2024 to 2031.

• According to Cognitive Market Research, the China Cardiovascular Surgical Devices market size was valued at USD 263.12 million in 2024 and is projected to grow at a CAGR of 5.3% during the forecast period. Cardiovascular Surgical Devices sales surge in China due to improving access to healthcare services.
• The Japan Cardiovascular Surgical Devices market is projected to witness growth at a CAGR of 4.3% during the forecast period, with a market size of USD 80.69 million in 2024.
• The India Cardiovascular Surgical Devices market had a market share of USD 70.16 million in 2024 and is projected to grow at a CAGR of 7.6% during the forecast period. India's aging population augment the demand encourage adoption of healthcare devices.
• The South Korea Cardiovascular Surgical Devices market is projected to witness growth at a CAGR of 4.9% during the forecast period, with a market size of USD 58.47 million in 2024.
• The Australia Cardiovascular Surgical Devices market is projected to witness growth at a CAGR of 5.5% during the forecast period, with a market size of USD 30.40 million in 2024.
• The South East Asia Cardiovascular Surgical Devices market is projected to witness growth at a CAGR of 6.8% during the forecast period, with a market size of USD 40.34 million in 2024.
• The Rest of Asia Pacific Cardiovascular Surgical Devices market is projected to witness growth at a CAGR of 5.6% during the forecast period, with a market size of USD 41.51 million in 2024.

South America Cardiovascular Surgical Devices Market

According to Cognitive Market Research, the global Cardiovascular Surgical Devices market size was estimated at USD 2,542.2 Million out of which Latin America market of more than 5% of the global revenue with a market size of USD 127.11 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.2% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil Cardiovascular Surgical Devices market size was valued at USD 54.40 million in 2024 and is projected to grow at a CAGR of 3.8% during the forecast period. Cardiovascular Surgical Devices sales flourish in Brazil due to improving healthcare infrastructure, increasing awareness about cardiovascular diseases, and rising healthcare expenditure.
• Argentina Cardiovascular Surgical Devices market had a market share of USD 21.35 million in 2024 and is projected to grow at a CAGR of 4.1% during the forecast period. Argentina's advancements in medical technology augment the demand to drive innovation in the healthcare industry.
• Colombia Cardiovascular Surgical Devices market is projected to witness growth at a CAGR of 3.0% during the forecast period with a market size of USD 11.31 million in 2024.
• Peru Cardiovascular Surgical Devices market is projected to witness growth at a CAGR of 3.4% during the forecast period with a market size of USD 10.42 million in 2024.
• Chile Cardiovascular Surgical Devices market is projected to witness growth at a CAGR of 3.5% during the forecast period with a market size of USD 9.15 million in 2024.
• The Rest of Latin America Cardiovascular Surgical Devices market is projected to witness growth at a CAGR of 2.3% during the forecast period, with a market size of USD 20.46 million in 2024.

Middle East and Africa Cardiovascular Surgical Devices Market

According to Cognitive Market Research, the global Cardiovascular Surgical Devices market size was estimated at USD 2,542.2 Million, out of which the Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD 50.84 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.5% from 2024 to 2031.

• The GCC Countries Cardiovascular Surgical Devices market is projected to witness growth at a CAGR of 4.3% during the forecast period with a market size of USD 21.76 million in 2024. Cardiovascular Surgical Devices sales flourish due to increasing healthcare spending.
• The Egypt Cardiovascular Surgical Devices market is projected to witness growth at a CAGR of 3.8% during the forecast period, with a market size of USD 5.34 million in 2024.
• The South Africa Cardiovascular Surgical Devices market is projected to witness growth at a CAGR of 4.5% during the forecast period, with a market size of USD 8.03 million in 2024. Cardiovascular Surgical Devices sales flourish in South Africa due to expanding healthcare infrastructure.
• The Turkey Cardiovascular Surgical Devices market is projected to witness growth at a CAGR of 3.0% during the forecast period, with a market size of USD 4.37 million in 2024.
• The Nigeria Cardiovascular Surgical Devices market is projected to witness growth at a CAGR of 2.6% during the forecast period, with a market size of USD 5.34 million in 2024.
• The Rest of MEA Cardiovascular Surgical Devices market is projected to witness growth at a CAGR of 2.5% during the forecast period, with a market size of USD 6.00 million in 2024.

Cardiovascular Surgical Devices Market Analysis

Cardiovascular Surgical Devices Market Type Segment Analysis

According to Cognitive Market Research, Interventional Cardiac Surgery stands out as the dominating category. Interventional cardiac surgery types have captured the largest market share in the cardiovascular surgical devices market due to their minimally invasive nature and effectiveness in treating cardiovascular conditions. These procedures, such as angioplasty and stenting, offer reduced recovery times, fewer complications, and better patient outcomes compared to traditional open-heart surgeries. Increasing preference for less invasive treatments, advancements in device technology, and expanding applications in treating coronary artery disease and structural heart defects drive the dominance of interventional cardiac surgery devices.

Cardiac rhythm management devices are experiencing the highest compound annual growth rate (CAGR) in the cardiovascular surgical devices market due to increasing prevalence of arrhythmias and heart failure, particularly among aging populations. These devices, including pacemakers and implantable cardioverter defibrillators (ICDs), are critical for managing and correcting irregular heart rhythms, thereby improving patient quality of life and reducing mortality rates. Technological advancements, such as miniaturization and longer battery life, further enhance their adoption and efficacy, driving market growth.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Cardiovascular Surgical Devices Industry. Request a Free Sample PDF!

Cardiovascular Surgical Devices Market Technology Segment Analysis

According to Cognitive Market Research, the dominating category is Perfusion Disposables. Perfusion disposables technology has captured the largest market share in the cardiovascular surgical devices market due to its essential role in cardiac surgeries requiring cardiopulmonary bypass (CPB). These devices, including oxygenators, tubing sets, and filters, are crucial for maintaining blood circulation and oxygenation during procedures like coronary artery bypass grafting (CABG) and heart valve surgeries. Advancements in perfusion technology, such as improved biocompatibility and efficiency, have bolstered their adoption, contributing to their dominance in the market.

Cardiopulmonary bypass (CPB) equipment technology is experiencing the highest compound annual growth rate (CAGR) in the cardiovascular surgical devices market due to its critical role in complex cardiac surgeries. CPB machines facilitate temporary heart and lung function during procedures like open-heart surgery, enabling surgeons to operate on a still and bloodless field. Increasing prevalence of cardiovascular diseases, advancements in CPB technology enhancing safety and efficacy, and rising demand for cardiac surgeries contribute to the rapid growth of this segment.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Cardiovascular Surgical Devices End User Segment Analysis

End User Segment Analysis

According to Cognitive Market Research, the dominating end user is Hospitals. Hospitals dominate the cardiovascular surgical devices market due to their role as primary healthcare providers for cardiovascular procedures. They have extensive infrastructure, specialized surgical teams, and advanced technologies necessary for performing complex surgeries and interventions. Hospitals also benefit from economies of scale, centralization of healthcare services, and strong referral networks, enhancing their ability to handle a wide range of cardiovascular cases. As a result, hospitals are the largest end-user channel in the market, driving significant demand for cardiovascular surgical devices.

Ambulatory surgical centers (ASCs) are experiencing the highest compound annual growth rate (CAGR) in the cardiovascular surgical devices market due to several factors. These include advancements in minimally invasive procedures, which are increasingly performed in ASCs for their convenience, reduced costs, and quicker recovery times compared to traditional hospital settings. Moreover, growing patient preference for outpatient procedures, coupled with expanding ASC capabilities and favorable reimbursement policies, contributes to the rising adoption of cardiovascular surgical devices in these settings.

• Hospitals
• Ambulatory Surgical Centres
• Narrow Aisle Forks
• Rotating Forks
• Others

Author's Detail

David Fuller

Senior Analyst at Cognitive Market Research

LinkedIn

Profile

I am working as a Senior Analyst with Cognitive Market Research in the areas of Industry Survey and Market Research/Analytics. I collaborate with CXOs, VPs, and other senior executives to understand their data needs and provide solutions and business strategy building.

Author's Conclusion